The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
ANKURDRUGS Key Metrics
ANKURDRUGS Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
ANKURDRUGS Share Price
ANKURDRUGS
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ANKURDRUGS Stock Analysis
Views
Red Flags
Positive
Not enough talking point with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ANKURDRUGS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ANKURDRUGS Bulk, Block & Insider Trades
ANKURDRUGS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Key personnel
Purnandu JainD
Chairman of the Board, Managing Director
S. C. Rane
Compliance Officer, Company Secretary
Girraj VijayvargiyaD
Wholetime Executive Director
Ramesh BathamD
Non-Executive Independent Director
Shri. Dileep H. ShindeD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently Asked Questions about ANKURDRUGS
The current share price of Ankur Drugs and Pharma Ltd is ₹ 3.65 as of 12 May 2017.
The Price-to-Earnings (PE) ratio of Ankur Drugs and Pharma Ltd is - as of the latest financial data.
Ankur Drugs and Pharma Ltd has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
The market capitalization of Ankur Drugs and Pharma Ltd stands at -.
The dividend yield of Ankur Drugs and Pharma Ltd is - based on the current market price.
The Relative Strength Index (RSI) of Ankur Drugs and Pharma Ltd is 29.29.
Foreign Institutional Investors (FII) hold - and Domestic Institutional Investors (DII) hold - of Ankur Drugs and Pharma Ltd shares.
Ankur Drugs and Pharma Ltd operates in the Healthcare sector.
The beta of Ankur Drugs and Pharma Ltd stock is 0.03, indicating its volatility relative to the broader market.
